Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SR 146131

Known as: SR-146131, SR146131 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Allosteric modulation of receptors provides mechanistic safety while effectively achieving biologic endpoints otherwise difficult… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
2002
2002
Abstract Rationale. Converging evidence has demonstrated that cholecystokinin (CCK) inhibits mesolimbic brain dopamine (DA… Expand
  • figure 1
  • figure 2
  • figure 3
2000
2000
1-[2-(4-(2-Chlorophenyl)thiazol-2-yl) aminocarbonyl indoyl] acetic acid (SR 27897) is an effective CCK(1) receptor antagonist… Expand
2000
2000
The effect of ¿2-[4-(4-chloro-2, 5-dimethoxy-phenyl)-5-[2-cyclohexyl-ethyl)-thiazol-2-ylcarbamoy l]-5, 7-dimethyl-indol-1-yl… Expand
2000
2000
We hypothesized that charge-charge interactions may be important for the binding of the human cholecystokinin type 1 (CCK(1… Expand
1999
1999
SR146131 inhibited the binding of [125I]-Bolton Hunter (BH)-sulfated cholecystokinin octapeptide (CCK-8S) for the human… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 6
1999
1999
SR146131 is a potent and selective agonist at cholecystokinin subtype 1 (CCK1) receptors in vitro. The present study evaluates… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5